Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
BACKGROUND: Ulcerative Colitis (UC) and Crohn's Disease (CD) are two chronic Inflammatory Bowel Diseases (IBD) affecting the intestinal mucosa. Current understanding of IBD pathogenesis points out the interplay of genetic events and environmental cues in the dysregulated immune response. We hyp...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2950152?pdf=render |
id |
doaj-936c66beec4a412d86a9691207f30346 |
---|---|
record_format |
Article |
spelling |
doaj-936c66beec4a412d86a9691207f303462020-11-24T21:35:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-01-01510e100093810.1371/journal.pone.0013160Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.Magali FasseuXavier TrétonCécile GuichardEric PedruzziDominique Cazals-HatemChristophe RichardThomas AparicioFanny DanielJean-Claude SouléRichard MoreauYoram BouhnikMarc LaburtheAndré GroyerEric Ogier-DenisBACKGROUND: Ulcerative Colitis (UC) and Crohn's Disease (CD) are two chronic Inflammatory Bowel Diseases (IBD) affecting the intestinal mucosa. Current understanding of IBD pathogenesis points out the interplay of genetic events and environmental cues in the dysregulated immune response. We hypothesized that dysregulated microRNA (miRNA) expression may contribute to IBD pathogenesis. miRNAs are small, non-coding RNAs which prevent protein synthesis through translational suppression or mRNAs degradation, and regulate several physiological processes. METHODOLOGY/FINDINGS: Expression of mature miRNAs was studied by Q-PCR in inactive colonic mucosa of patients with UC (8), CD (8) and expressed relative to that observed in healthy controls (10). Only miRNAs with highly altered expression (>5 or <0.2 -fold relative to control) were considered when Q-PCR data were analyzed. Two subsets of 14 (UC) and 23 (CD) miRNAs with highly altered expression (5.2->100 -fold and 0.05-0.19 -fold for over- and under- expression, respectively; 0.001<p≤0.05) were identified in quiescent colonic mucosa, 8 being commonly dysregulated in non-inflamed UC and CD (mir-26a,-29a,-29b,-30c,-126*,-127-3p,-196a,-324-3p). Several miRNA genes with dysregulated expression co-localize with acknowledged IBD-susceptibility loci while others, (eg. clustered on 14q32.31), map on chromosomal regions not previously recognized as IBD-susceptibility loci. In addition, in silico clustering analysis identified 5 miRNAs (mir-26a,-29b,-126*,-127-3p,-324-3p) that share coordinated dysregulation of expression both in quiescent and in inflamed colonic mucosa of IBD patients. Six miRNAs displayed significantly distinct alteration of expression in non-inflamed colonic biopsies of UC and CD patients (mir-196b,-199a-3p,-199b-5p,-320a,-150,-223). CONCLUSIONS/SIGNIFICANCE: Our study supports miRNAs as crucial players in the onset and/or relapse of inflammation from quiescent mucosal tissues in IBD patients. It allows speculating a role for miRNAs as contributors to IBD susceptibility and suggests that some of the miRNA with altered expression in the quiescent mucosa of IBD patients may define miRNA signatures for UC and CD and help develop new diagnostic biomarkers.http://europepmc.org/articles/PMC2950152?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Magali Fasseu Xavier Tréton Cécile Guichard Eric Pedruzzi Dominique Cazals-Hatem Christophe Richard Thomas Aparicio Fanny Daniel Jean-Claude Soulé Richard Moreau Yoram Bouhnik Marc Laburthe André Groyer Eric Ogier-Denis |
spellingShingle |
Magali Fasseu Xavier Tréton Cécile Guichard Eric Pedruzzi Dominique Cazals-Hatem Christophe Richard Thomas Aparicio Fanny Daniel Jean-Claude Soulé Richard Moreau Yoram Bouhnik Marc Laburthe André Groyer Eric Ogier-Denis Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS ONE |
author_facet |
Magali Fasseu Xavier Tréton Cécile Guichard Eric Pedruzzi Dominique Cazals-Hatem Christophe Richard Thomas Aparicio Fanny Daniel Jean-Claude Soulé Richard Moreau Yoram Bouhnik Marc Laburthe André Groyer Eric Ogier-Denis |
author_sort |
Magali Fasseu |
title |
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. |
title_short |
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. |
title_full |
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. |
title_fullStr |
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. |
title_full_unstemmed |
Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. |
title_sort |
identification of restricted subsets of mature microrna abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2010-01-01 |
description |
BACKGROUND: Ulcerative Colitis (UC) and Crohn's Disease (CD) are two chronic Inflammatory Bowel Diseases (IBD) affecting the intestinal mucosa. Current understanding of IBD pathogenesis points out the interplay of genetic events and environmental cues in the dysregulated immune response. We hypothesized that dysregulated microRNA (miRNA) expression may contribute to IBD pathogenesis. miRNAs are small, non-coding RNAs which prevent protein synthesis through translational suppression or mRNAs degradation, and regulate several physiological processes. METHODOLOGY/FINDINGS: Expression of mature miRNAs was studied by Q-PCR in inactive colonic mucosa of patients with UC (8), CD (8) and expressed relative to that observed in healthy controls (10). Only miRNAs with highly altered expression (>5 or <0.2 -fold relative to control) were considered when Q-PCR data were analyzed. Two subsets of 14 (UC) and 23 (CD) miRNAs with highly altered expression (5.2->100 -fold and 0.05-0.19 -fold for over- and under- expression, respectively; 0.001<p≤0.05) were identified in quiescent colonic mucosa, 8 being commonly dysregulated in non-inflamed UC and CD (mir-26a,-29a,-29b,-30c,-126*,-127-3p,-196a,-324-3p). Several miRNA genes with dysregulated expression co-localize with acknowledged IBD-susceptibility loci while others, (eg. clustered on 14q32.31), map on chromosomal regions not previously recognized as IBD-susceptibility loci. In addition, in silico clustering analysis identified 5 miRNAs (mir-26a,-29b,-126*,-127-3p,-324-3p) that share coordinated dysregulation of expression both in quiescent and in inflamed colonic mucosa of IBD patients. Six miRNAs displayed significantly distinct alteration of expression in non-inflamed colonic biopsies of UC and CD patients (mir-196b,-199a-3p,-199b-5p,-320a,-150,-223). CONCLUSIONS/SIGNIFICANCE: Our study supports miRNAs as crucial players in the onset and/or relapse of inflammation from quiescent mucosal tissues in IBD patients. It allows speculating a role for miRNAs as contributors to IBD susceptibility and suggests that some of the miRNA with altered expression in the quiescent mucosa of IBD patients may define miRNA signatures for UC and CD and help develop new diagnostic biomarkers. |
url |
http://europepmc.org/articles/PMC2950152?pdf=render |
work_keys_str_mv |
AT magalifasseu identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT xaviertreton identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT cecileguichard identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT ericpedruzzi identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT dominiquecazalshatem identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT christopherichard identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT thomasaparicio identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT fannydaniel identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT jeanclaudesoule identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT richardmoreau identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT yorambouhnik identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT marclaburthe identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT andregroyer identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease AT ericogierdenis identificationofrestrictedsubsetsofmaturemicrornaabnormallyexpressedininactivecolonicmucosaofpatientswithinflammatoryboweldisease |
_version_ |
1725944291895803904 |